Berkeley, CA, United States of America

Ji-Yun Kim

This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignees: Bayer Healthcare LLC, Oklahoma Medical Research Foundation. Active years: 2016-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ji-Yun Kim. Retrieved from https://idiyas.com/inventor/ji-yun-kim-bpecnrer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 80.0

Average Co-Inventor Count = 6.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2022

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Ji-Yun Kim

Introduction

Ji-Yun Kim is a prominent inventor based in Berkeley, California, known for his significant contributions to the field of biotechnology. With a total of five patents to his name, he has made remarkable advancements in the development of humanized monoclonal antibodies.

Latest Patents

Among his latest patents are "Humanized monoclonal antibodies against activated protein C and uses thereof" and "Epitope of optimized humanized monoclonal antibodies against activated protein C and uses thereof." The first patent provides humanized antibodies that selectively bind to and inhibit activated protein C without affecting unactivated protein C. The second patent focuses on optimized humanized antibodies that bind to specific epitopes outside the catalytic triad of the active site of human activated protein C, detailing methods of treatment employing these antibodies.

Career Highlights

Ji-Yun Kim has worked with notable organizations such as Bayer Healthcare LLC and the Oklahoma Medical Research Foundation. His work in these institutions has contributed to the advancement of medical research and therapeutic applications.

Collaborations

Some of his notable coworkers include Xiao-Yan Zhao and Zhuozhi Wang, who have collaborated with him on various projects in the field of biotechnology.

Conclusion

Ji-Yun Kim's innovative work in the development of humanized monoclonal antibodies showcases his dedication to advancing medical science. His contributions continue to have a significant impact on the field of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…